Traduction de «incidence of hospital acquired » (Français → Néerlandais) :

Incidence of hospital acquired MRSA infections
% prescription of low-

12 Fischer TK, Bresee JS, Glass RI: Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children.,
12 Fischer TK, Bresee JS, Glass RI: Rotavirus vaccines and the prevention of hospital-acquired diarrhea in children.

French G.L. Prevention of Hospital-acquired Aspergillosis Infection During Demolition and Building Work.
HGR - Hoge Gezondheidsraad. Aanbevelingen ter voorkoming van Legionella-infecties in verzorgingsinrichtingen.

12. Campillo B, Dupeyron C et al : Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis
12. Campillo B, Dupeyron C et al: Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis

72. Evans RS et al : Computer surveillance of hospital acquired infections and antibiotic use.
72. Evans RS et al: Computer surveillance of hospital acquired infections and antibiotic use.

Long term care hospitals have mainly submitted projects with regard to medication, hospital hygiene, fall prevention and registration and analysis of incidents and near incidents.
Long term care hospitals have mainly submitted projects with regard to medication, hospital hygiene, fall prevention and registration and analysis of (near) incidents.

- Thompson R, Hall N, Szpiech M. Hospitalization and mortality rates for nursing home-acquired pneumonia.
- Thompson R, Hall N Szpiech M. Hospitalization and mortality rates for nursing home-acquired pneumonia.

48. King JW et al : Altérations in the micro-flore and the incidence of bacteremia et a university hospital after adoption of amikacin as the sole formulary aminoglucoside.
48. King JW et al: Alterations in the micro-flore and the incidence of bacteremia et a university hospital after adoption of amikacin as the sole formulary aminoglucoside.

Dans deux études (l’Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study [EPHESUS] et l’Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure [EMPHASIS-HF]), l'incidence globale d'événements indésirables décrits avec l'éplérénone était similaire à celle observée avec le placebo.
In twee onderzoeken (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study [EPHESUS] en Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure [EMPHASIS-HF]) was de globale incidentie van bijwerkingen die met eplerenone werden beschreven gelijk aan de incidentie waargenomen met placebo.